HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Shareholders Push For More Power Over Board Membership

This article was originally published in The Rose Sheet

Executive Summary

Firm’s shareholders will be able to make board changes via simple majority votes (versus super-majority votes) if P&G adopts a proposal backed by a 59.3% of shareholders at an Oct. 9 meeting. The change could allow a shakeup of P&G leadership, with rumors circulating that activist investor William Ackman wants CEO Bob McDonald out.

You may also be interested in...



P&G Cost-Cutting Successes Inspire New Moves In Productivity

P&G has “identified and will appoint” a senior group president to new position of global officer, productivity and organization transformation, firm announces during first quarter conference call Oct. 25. Cost-cutting measures contributed to higher EPS than initially estimated.

P&G Defends Savings/Growth Strategy, Plans To Slash More Prices In FY 2013

P&G will roll back about $400 million of the $3.5 billion in pricing increases taken in fiscal year 2012, in an effort to include beauty and health-care products. Beauty sales declined 4% on the year, the firm reported.

Activist Investor May Urge P&G To Lose Non-Core Brands, McDonald

Changes may be ahead for Procter & Gamble following William Ackman and Pershing Square Capital Management’s investment in the Cincinnati-based consumer-goods giant. Analysts suggest the activist investor may push to replace CEO Bob McDonald and divest non-core brands.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018320

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel